| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | hippo signaling | 6.77e-07 | 55 | 117 | 6 | GO:0035329 | |
| GeneOntologyBiologicalProcess | heart development | COL2A1 KAT6A SHOX2 ZMIZ1 PDLIM5 RYR1 HEXIM1 NRP2 STK3 BMP5 MAPK14 GPC3 XIRP2 FLRT3 FLRT2 MAP2K3 GAB1 | 1.29e-06 | 757 | 117 | 17 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of hippo signaling | 2.66e-06 | 39 | 117 | 5 | GO:0035330 | |
| GeneOntologyBiologicalProcess | negative regulation of hippo signaling | 6.65e-06 | 22 | 117 | 4 | GO:0035331 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR3 CDH23 CLDN3 TENM2 CDH22 MAPK14 TENM3 FLRT3 PCDH7 CDH13 | 1.19e-05 | 313 | 117 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell junction organization | CDHR3 CHD4 CLDN3 PDLIM5 NRP2 ACE2 CDH22 MAPK14 CSF1R SHANK2 TENM3 XIRP2 PIP5K1A FLRT3 FLRT2 PEAK1 CDH13 | 3.50e-05 | 974 | 117 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SZT2 UNC5B CDHR3 CDH23 SHOX2 CLDN3 CIT TENM2 PDLIM5 NRP2 SHROOM4 CDH22 MAPK14 LATS2 CSF1R FLRT3 FLRT2 MUL1 CDH13 | 4.11e-05 | 1194 | 117 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 CYP1B1 UNC5B KAT6A SHOX2 ZMIZ1 PDLIM5 RYR1 HEXIM1 NRP2 STK3 BMP5 MAPK14 GPC3 XIRP2 EGR3 FLRT3 FLRT2 MAP2K3 CDH13 GAB1 | 5.62e-05 | 1442 | 117 | 21 | GO:0072359 |
| GeneOntologyBiologicalProcess | cellular response to vascular endothelial growth factor stimulus | 7.22e-05 | 76 | 117 | 5 | GO:0035924 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 9.08e-05 | 321 | 117 | 9 | GO:0003007 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | COL2A1 ZMIZ1 RYR1 NRP2 BMP5 MAPK14 TOB1 LATS2 GPC3 EGR3 TLR4 FLRT3 FLRT2 MAP2K3 GAB1 | 9.32e-05 | 850 | 117 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | cell junction assembly | CDHR3 CHD4 CLDN3 PDLIM5 ACE2 CDH22 SHANK2 PIP5K1A FLRT3 FLRT2 PEAK1 CDH13 | 9.54e-05 | 569 | 117 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CYP1B1 KIF26B CDHR3 CDH23 CLDN3 ZMIZ1 TENM2 PDLIM5 BMP5 CDH22 MAPK14 TENM3 EGR3 LRRC7 FLRT3 PCDH7 CDH13 | 1.21e-04 | 1077 | 117 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | response to growth factor | COL2A1 ZMIZ1 RYR1 NRP2 BMP5 MAPK14 TOB1 LATS2 GPC3 EGR3 TLR4 FLRT3 FLRT2 MAP2K3 GAB1 | 1.42e-04 | 883 | 117 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.32e-04 | 53 | 117 | 4 | GO:0016339 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 7.85e-06 | 230 | 121 | 9 | GO:0019898 | |
| GeneOntologyCellularComponent | catenin complex | 3.39e-05 | 32 | 121 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | glutamatergic synapse | HIP1 SYN3 CHD4 GRIK5 TENM2 NRP2 RNF220 MAPK14 SHANK2 TENM3 CADPS SYN2 LRRC7 FLRT3 FLRT2 | 7.62e-05 | 817 | 121 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.47e-04 | 137 | 121 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | piP-body | 3.29e-04 | 5 | 121 | 2 | GO:0071547 | |
| GeneOntologyCellularComponent | anchoring junction | CDHR3 CLDN3 TENM2 PDLIM5 SHROOM4 CDH22 XIRP2 PIP5K1A LRRC7 FLRT3 FLRT2 SSH2 PEAK1 CDH13 GAB1 | 5.18e-04 | 976 | 121 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | CDHR3 CLDN3 TENM2 PDLIM5 SHROOM4 CDH22 LRRC7 FLRT3 FLRT2 CDH13 GAB1 | 6.48e-04 | 591 | 121 | 11 | GO:0005911 |
| Domain | - | 7.06e-05 | 13 | 120 | 3 | 3.40.50.20 | |
| Domain | PreATP-grasp_dom | 8.94e-05 | 14 | 120 | 3 | IPR016185 | |
| Domain | - | 1.11e-04 | 15 | 120 | 3 | 3.30.1490.20 | |
| Domain | Rhs_assc_core | 1.22e-04 | 3 | 120 | 2 | IPR022385 | |
| Domain | Synapsin_pre-ATP-grasp_dom | 1.22e-04 | 3 | 120 | 2 | IPR020897 | |
| Domain | Synapsin_ATP-bd_dom | 1.22e-04 | 3 | 120 | 2 | IPR020898 | |
| Domain | SYNAPSIN_1 | 1.22e-04 | 3 | 120 | 2 | PS00415 | |
| Domain | SYNAPSIN_2 | 1.22e-04 | 3 | 120 | 2 | PS00416 | |
| Domain | Synapsin_C | 1.22e-04 | 3 | 120 | 2 | PF02750 | |
| Domain | Synapsin_N | 1.22e-04 | 3 | 120 | 2 | PF10581 | |
| Domain | Synapsin_CS | 1.22e-04 | 3 | 120 | 2 | IPR019735 | |
| Domain | Synapsin_P_site | 1.22e-04 | 3 | 120 | 2 | IPR019736 | |
| Domain | Synapsin | 1.22e-04 | 3 | 120 | 2 | PF02078 | |
| Domain | Synapsin | 1.22e-04 | 3 | 120 | 2 | IPR001359 | |
| Domain | ATP_grasp_subdomain_1 | 1.97e-04 | 18 | 120 | 3 | IPR013815 | |
| Domain | - | 1.97e-04 | 18 | 120 | 3 | 3.30.470.20 | |
| Domain | Tox-GHH_dom | 2.44e-04 | 4 | 120 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.44e-04 | 4 | 120 | 2 | PF15636 | |
| Domain | Ten_N | 2.44e-04 | 4 | 120 | 2 | IPR009471 | |
| Domain | Ten_N | 2.44e-04 | 4 | 120 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.44e-04 | 4 | 120 | 2 | PS51361 | |
| Domain | YD | 4.04e-04 | 5 | 120 | 2 | IPR006530 | |
| Domain | RING | 7.98e-04 | 305 | 120 | 8 | SM00184 | |
| Domain | CADHERIN_1 | 8.13e-04 | 113 | 120 | 5 | PS00232 | |
| Domain | Cadherin | 8.13e-04 | 113 | 120 | 5 | PF00028 | |
| Domain | Glyco_hydro_47 | 8.42e-04 | 7 | 120 | 2 | PF01532 | |
| Domain | - | 8.42e-04 | 7 | 120 | 2 | 1.50.10.50 | |
| Domain | CADHERIN_2 | 8.46e-04 | 114 | 120 | 5 | PS50268 | |
| Domain | - | 8.46e-04 | 114 | 120 | 5 | 2.60.40.60 | |
| Domain | CA | 8.80e-04 | 115 | 120 | 5 | SM00112 | |
| Domain | Cadherin-like | 9.15e-04 | 116 | 120 | 5 | IPR015919 | |
| Domain | Cadherin | 9.88e-04 | 118 | 120 | 5 | IPR002126 | |
| Domain | ATP_grasp_subdomain_2 | 1.02e-03 | 31 | 120 | 3 | IPR013816 | |
| Domain | Glyco_hydro_47 | 1.12e-03 | 8 | 120 | 2 | IPR001382 | |
| Domain | LRRCT | 1.12e-03 | 32 | 120 | 3 | PF01463 | |
| Domain | Znf_RING | 1.22e-03 | 326 | 120 | 8 | IPR001841 | |
| Pubmed | 2.88e-08 | 10 | 121 | 4 | 38713721 | ||
| Pubmed | Directed migration of cortical interneurons depends on the cell-autonomous action of Sip1. | 7.97e-07 | 21 | 121 | 4 | 23312517 | |
| Pubmed | FLRT structure: balancing repulsion and cell adhesion in cortical and vascular development. | 1.42e-06 | 7 | 121 | 3 | 25374360 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | AFF2 SZT2 ZMIZ1 TENM2 PDLIM5 RYR1 HEXIM1 SHROOM4 TMEM120A SHANK2 GALNT4 | 3.86e-06 | 552 | 121 | 11 | 10737800 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 7.30e-06 | 377 | 121 | 9 | 38117590 | |
| Pubmed | FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. | 8.83e-06 | 12 | 121 | 3 | 21673655 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 17167049 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32383269 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17686961 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17406030 | ||
| Pubmed | Inflammatory intracellular pathways activated by electronegative LDL in monocytes. | 1.20e-05 | 2 | 121 | 2 | 27235719 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27402810 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17182102 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20702616 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 37643860 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33505220 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15626329 | ||
| Pubmed | Circulating free heme induces cytokine storm and pulmonary hypertension through the MKK3/p38 axis. | 1.20e-05 | 2 | 121 | 2 | 39197168 | |
| Pubmed | 1.34e-05 | 407 | 121 | 9 | 12693553 | ||
| Pubmed | 1.81e-05 | 15 | 121 | 3 | 34301831 | ||
| Pubmed | 3.32e-05 | 52 | 121 | 4 | 26633812 | ||
| Pubmed | p38α Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis. | 3.59e-05 | 3 | 121 | 2 | 21610252 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23245320 | ||
| Pubmed | Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles. | 3.59e-05 | 3 | 121 | 2 | 18945891 | |
| Pubmed | Different presynaptic roles of synapsins at excitatory and inhibitory synapses. | 3.59e-05 | 3 | 121 | 2 | 15601943 | |
| Pubmed | Compensatory network alterations upon onset of epilepsy in synapsin triple knock-out mice. | 3.59e-05 | 3 | 121 | 2 | 21621590 | |
| Pubmed | PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. | 3.59e-05 | 3 | 121 | 2 | 20418886 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 37046278 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19487674 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10644439 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15516490 | ||
| Pubmed | Autism-related behavioral abnormalities in synapsin knockout mice. | 3.59e-05 | 3 | 121 | 2 | 23280234 | |
| Pubmed | Synapsin Isoforms Regulating GABA Release from Hippocampal Interneurons. | 3.59e-05 | 3 | 121 | 2 | 27335405 | |
| Pubmed | The Lack of Synapsin Alters Presynaptic Plasticity at Hippocampal Mossy Fibers in Male Mice. | 3.59e-05 | 3 | 121 | 2 | 38866497 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 32429593 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20804820 | ||
| Pubmed | Synapsins differentially control dopamine and serotonin release. | 3.59e-05 | 3 | 121 | 2 | 20660258 | |
| Pubmed | Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons. | 3.59e-05 | 3 | 121 | 2 | 15644321 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17588539 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18827744 | ||
| Pubmed | Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. | 3.59e-05 | 3 | 121 | 2 | 16357362 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22447969 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 29138810 | ||
| Pubmed | GPC3-Unc5 receptor complex structure and role in cell migration. | 3.59e-05 | 3 | 121 | 2 | 36240740 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25315223 | ||
| Pubmed | TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. | 3.59e-05 | 3 | 121 | 2 | 24445575 | |
| Pubmed | Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. | 3.59e-05 | 3 | 121 | 2 | 15778394 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 28245069 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 8626699 | ||
| Pubmed | Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals. | 3.59e-05 | 3 | 121 | 2 | 22442064 | |
| Pubmed | Synapsin condensation controls synaptic vesicle sequestering and dynamics. | 3.59e-05 | 3 | 121 | 2 | 37872159 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10578110 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25610812 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 7750576 | ||
| Pubmed | Maternal synapsin autoantibodies are associated with neurodevelopmental delay. | 3.59e-05 | 3 | 121 | 2 | 36742338 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22805168 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 26573508 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23236212 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23492809 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15797859 | ||
| Pubmed | Angiopoietin-2 mediates thrombin-induced monocyte adhesion and endothelial permeability. | 3.59e-05 | 3 | 121 | 2 | 27241812 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 38472171 | ||
| Pubmed | The readily-releasable pool dynamically regulates multivesicular release. | 3.59e-05 | 3 | 121 | 2 | 31364987 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27515700 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22933803 | ||
| Pubmed | Differential activation of p38MAPK isoforms by MKK6 and MKK3. | 3.59e-05 | 3 | 121 | 2 | 20004242 | |
| Pubmed | Synaptic vesicle mobility in mouse motor nerve terminals with and without synapsin. | 3.59e-05 | 3 | 121 | 2 | 18077680 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 28922833 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22846639 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22368083 | ||
| Pubmed | p38α MAPK is required for tooth morphogenesis and enamel secretion. | 3.59e-05 | 3 | 121 | 2 | 25406311 | |
| Pubmed | p38 MAPK α and β isoforms differentially regulate plasma membrane localization of MRP2. | 3.59e-05 | 3 | 121 | 2 | 27012769 | |
| Pubmed | Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. | 3.59e-05 | 3 | 121 | 2 | 16554471 | |
| Pubmed | Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC. | 3.59e-05 | 3 | 121 | 2 | 22164285 | |
| Pubmed | 3.82e-05 | 19 | 121 | 3 | 23776616 | ||
| Pubmed | 3.96e-05 | 263 | 121 | 7 | 34702444 | ||
| Pubmed | MYT1L TRPM7 CEP85L CHD4 POGZ REV3L CIT PDLIM5 RNF220 MAN1A2 CADPS CEP70 TRIM8 USP7 EIF3D | 4.16e-05 | 1285 | 121 | 15 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TRPM7 RIMKLA CEP85L KIF26B RALGAPB TTK TAB3 STK3 SSH2 PEAK1 PCDH7 GAB1 | 4.88e-05 | 861 | 121 | 12 | 36931259 |
| Pubmed | DNAH10 KAT6A NSD1 STK3 MAPK14 LATS2 PIP5K1A SSH2 DNASE2 GALNT4 ADSS1 | 5.10e-05 | 730 | 121 | 11 | 34857952 | |
| Pubmed | Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology. | 5.22e-05 | 21 | 121 | 3 | 26234751 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 36482494 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 15143069 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 29057902 | ||
| Pubmed | The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation. | 7.17e-05 | 4 | 121 | 2 | 34331453 | |
| Pubmed | Translational control of NKT cell cytokine production by p38 MAPK. | 7.17e-05 | 4 | 121 | 2 | 21368234 | |
| Pubmed | FLRT3 Marks Direction-Selective Retinal Ganglion Cells That Project to the Medial Terminal Nucleus. | 7.17e-05 | 4 | 121 | 2 | 34955746 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 7.17e-05 | 4 | 121 | 2 | 10225957 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 15864310 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 25012660 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 25266658 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 8622669 | ||
| Pubmed | TRPM7 activates m-calpain by stress-dependent stimulation of p38 MAPK and c-Jun N-terminal kinase. | 7.17e-05 | 4 | 121 | 2 | 20070945 | |
| Pubmed | The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. | 7.17e-05 | 4 | 121 | 2 | 11593045 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 19122179 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 29343440 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 25233930 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 20023695 | ||
| Pubmed | p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection. | 7.17e-05 | 4 | 121 | 2 | 15778378 | |
| Pubmed | Phospholipase C-beta 2 interacts with mitogen-activated protein kinase kinase 3. | 7.17e-05 | 4 | 121 | 2 | 12054652 | |
| Pubmed | IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin. | 7.17e-05 | 4 | 121 | 2 | 34325726 | |
| Interaction | DUSP2 interactions | 8.86e-06 | 81 | 120 | 6 | int:DUSP2 | |
| Interaction | RND1 interactions | 1.68e-05 | 246 | 120 | 9 | int:RND1 | |
| Interaction | LOC102724159 interactions | 1.68e-05 | 9 | 120 | 3 | int:LOC102724159 | |
| Cytoband | Xp22.12 | 1.91e-04 | 8 | 121 | 2 | Xp22.12 | |
| GeneFamily | Synapsins | 5.22e-05 | 3 | 76 | 2 | 1325 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYT1L DOK6 AFF2 TMEM185B SYN3 CEP85L SHOX2 ZMIZ1 REV3L TENM2 NRP2 CDH22 SHANK2 CADPS SYN2 MAP7D2 LRRC7 SSH2 MAP2K3 PCDH7 HYDIN CDH13 | 5.67e-09 | 1106 | 120 | 22 | M39071 |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN | 3.69e-07 | 200 | 120 | 9 | M4039 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | ARHGAP42 DOK6 HIP1 KIF26B TENM2 SHROOM4 RNF220 SHANK2 SUGCT PIP5K1A | 2.28e-05 | 417 | 120 | 10 | M39224 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | ARHGAP42 MBTPS1 TRPM7 RALGAPB SLU7 ZMIZ1 REV3L PDLIM5 SNX13 BMP5 MAN1A2 PCDH7 | 1.34e-06 | 375 | 119 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ARHGAP42 MBTPS1 RTL6 SZT2 KIF26B SLU7 CLDN3 ZMIZ1 REV3L TENM2 NRP2 BMP5 MAN1A2 CADPS FLRT2 RNF24 PCDH7 | 2.58e-06 | 806 | 119 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | MBTPS1 TRPM7 NSD1 CHD4 REV3L MYSM1 PDLIM5 SNX13 MAN1A2 USP7 PCDH7 | 3.32e-06 | 339 | 119 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000 | CYP1B1 MBTPS1 ACTR10 CHD4 ZMIZ1 REV3L PDLIM5 ACE2 HOXC5 MAN1A2 LATS2 TLR4 TRIM8 USP7 EDEM1 DNASE2 ADSS1 | 4.28e-06 | 837 | 119 | 17 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.19e-05 | 388 | 119 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.57e-05 | 259 | 119 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.66e-05 | 277 | 119 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 3.76e-05 | 163 | 119 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 3.91e-05 | 164 | 119 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | ARHGAP42 CYP1B1 AFF2 KIF26B NEK7 ME1 ACE2 BMP5 HOXC5 GPC3 TENM3 CEP70 FLRT3 PEAK1 PCDH7 | 3.98e-05 | 797 | 119 | 15 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.14e-05 | 226 | 119 | 8 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TRPM7 KIF26B NSD1 ZMIZ1 REV3L TENM2 PDLIM5 SNX13 NRP2 BMP5 MAN1A2 CADPS USP7 SYN2 FLRT3 | 5.34e-05 | 818 | 119 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_500 | 5.37e-05 | 37 | 119 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 7.00e-05 | 390 | 119 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | CYP1B1 AFF2 KIF26B REV3L ME1 ACE2 BMP5 HOXC5 TOB1 GPC3 TENM3 CADPS CEP70 FLRT3 PCDH7 | 8.11e-05 | 849 | 119 | 15 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.72e-05 | 323 | 119 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.03e-04 | 330 | 119 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | KIF26B SHOX2 ZMIZ1 REV3L TENM2 NRP2 BMP5 MAN1A2 LATS2 CADPS FLRT3 FLRT2 RNF24 PCDH7 | 1.04e-04 | 769 | 119 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ARHGAP42 MBTPS1 TRPM7 RALGAPB SLU7 CLDN3 ZMIZ1 REV3L PDLIM5 SNX13 BMP5 MAN1A2 TXNDC9 PCDH7 | 1.11e-04 | 774 | 119 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP42 CYP1B1 AFF2 KIF26B REV3L ME1 TTK PI15 ACE2 BMP5 HOXC5 GPC3 TENM3 PEAK1 | 1.16e-04 | 777 | 119 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | ARHGAP42 CYP1B1 AFF2 SZT2 NEK7 REV3L ME1 ACE2 BMP5 HOXC5 GPC3 TENM3 FLRT2 PEAK1 | 1.26e-04 | 783 | 119 | 14 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200 | 1.28e-04 | 138 | 119 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.36e-04 | 423 | 119 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | MYT1L TDRD9 TRPM7 AK7 MYSM1 RYR1 HOXC5 MEIOC SYN2 MAP7D2 PIP5K1A FLRT2 PEAK1 FHIP2B | 1.47e-04 | 795 | 119 | 14 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.75e-04 | 146 | 119 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.88e-04 | 281 | 119 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.95e-04 | 149 | 119 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.02e-04 | 284 | 119 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 2.97e-04 | 161 | 119 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | ANO4 CYP1B1 HIP1 KIF26B TENM2 NRP2 ACE2 BMP5 HOXC5 LATS2 TLR4 FLRT2 RNF24 ADSS1 | 3.10e-04 | 855 | 119 | 14 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | CYP1B1 AFF2 CEP85L KIF26B ME1 ACE2 BMP5 HOXC5 TOB1 GPC3 TENM3 CEP70 FLRT3 PCDH7 | 3.22e-04 | 858 | 119 | 14 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.72e-04 | 311 | 119 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | COL2A1 AFF2 TRPM7 RIMKLA CEP85L NSD1 CHD4 POGZ REV3L TTK KHDC4 CIT PI15 CDKAL1 BCLAF3 SHANK2 CEP70 USP7 FHIP2B | 4.76e-04 | 1459 | 119 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP42 CYP1B1 AFF2 KIF26B REV3L ME1 TTK ACE2 BMP5 HOXC5 GPC3 TENM3 CADPS | 5.08e-04 | 793 | 119 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | COL2A1 ARHGAP42 CYP1B1 AFF2 TRPM7 CEP85L NSD1 CHD4 TTK CIT PI15 CDKAL1 NRP2 GPC3 CEP70 USP7 FLRT3 FHIP2B ADSS1 | 5.13e-04 | 1468 | 119 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.18e-04 | 327 | 119 | 8 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | ARHGAP42 CYP1B1 AFF2 KIF26B NEK7 ME1 ACE2 BMP5 HOXC5 TENM3 CEP70 FLRT2 PEAK1 | 5.33e-04 | 797 | 119 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_500 | 5.46e-04 | 414 | 119 | 9 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | COL2A1 ARHGAP42 AFF2 TRPM7 CEP85L NSD1 CHD4 TTK CIT PI15 CDKAL1 GPC3 CEP70 USP7 FLRT3 FHIP2B ADSS1 | 5.53e-04 | 1241 | 119 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | MBTPS1 TRPM7 NSD1 CHD4 CLDN3 REV3L MYSM1 PDLIM5 SNX13 MAN1A2 USP7 MAP7D2 PCDH7 | 5.58e-04 | 801 | 119 | 13 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 5.64e-04 | 29 | 119 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.79e-04 | 68 | 119 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | TRPM7 UNC5B SHOX2 CIT MYSM1 BMP5 HOXC5 CADPS USP7 PIP5K1A FLRT3 FLRT2 FHIP2B | 6.56e-04 | 815 | 119 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 6.81e-04 | 427 | 119 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | ANO4 CYP1B1 PDLIM5 TXNL1 ACE2 CASP12 HOXC5 LATS2 MEIOC TLR4 FLRT2 RNF24 GAB1 | 6.87e-04 | 819 | 119 | 13 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.40e-04 | 432 | 119 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CYP1B1 AFF2 KIF26B REV3L ME1 TTK ACE2 BMP5 HOXC5 GPC3 TENM3 FLRT3 FLRT2 | 7.51e-04 | 827 | 119 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_100 | 7.57e-04 | 73 | 119 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CYP1B1 AFF2 SZT2 KIF26B ACE2 BMP5 HOXC5 GPC3 TENM3 CEP70 FLRT3 FLRT2 PCDH7 | 7.85e-04 | 831 | 119 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.69e-04 | 354 | 119 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 8.81e-04 | 76 | 119 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 8.81e-04 | 76 | 119 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 9.17e-04 | 357 | 119 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | ARHGAP42 CYP1B1 AFF2 SZT2 REV3L ME1 ACE2 BMP5 HOXC5 TENM3 FLRT2 PEAK1 | 9.24e-04 | 740 | 119 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 9.85e-04 | 361 | 119 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 9.86e-04 | 450 | 119 | 9 | GSM777063_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.00e-03 | 203 | 119 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 1.02e-03 | 79 | 119 | 4 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.04e-03 | 364 | 119 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_100 | 1.07e-03 | 36 | 119 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | RTL6 AFF2 SYN3 SZT2 RIMKLA KIF26B PI15 PDLIM5 GPC3 TENM3 CADPS FLRT3 FLRT2 PEAK1 PCDH7 CDH13 | 1.16e-03 | 1208 | 119 | 16 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_200 | 1.16e-03 | 37 | 119 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.17e-03 | 209 | 119 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.66e-08 | 192 | 121 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.64e-07 | 166 | 121 | 7 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 7.27e-07 | 184 | 121 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.11e-07 | 187 | 121 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 8.11e-07 | 187 | 121 | 7 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-07 | 188 | 121 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-07 | 188 | 121 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-07 | 188 | 121 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.02e-07 | 190 | 121 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.34e-07 | 191 | 121 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.67e-07 | 192 | 121 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.67e-07 | 192 | 121 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.00e-06 | 193 | 121 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.00e-06 | 193 | 121 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.04e-06 | 194 | 121 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 121 | 7 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.07e-06 | 195 | 121 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.07e-06 | 195 | 121 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-06 | 195 | 121 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.07e-06 | 195 | 121 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-06 | 195 | 121 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-06 | 196 | 121 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.11e-06 | 196 | 121 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.15e-06 | 197 | 121 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.15e-06 | 197 | 121 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 199 | 121 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.27e-06 | 200 | 121 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 121 | 7 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-06 | 157 | 121 | 6 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-06 | 157 | 121 | 6 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.87e-06 | 159 | 121 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.82e-06 | 164 | 121 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.46e-06 | 167 | 121 | 6 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 9.90e-06 | 180 | 121 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-06 | 180 | 121 | 6 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 181 | 121 | 6 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 181 | 121 | 6 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.02e-05 | 181 | 121 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 181 | 121 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 183 | 121 | 6 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 184 | 121 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 184 | 121 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 184 | 121 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.12e-05 | 184 | 121 | 6 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-05 | 185 | 121 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.16e-05 | 185 | 121 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 187 | 121 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.23e-05 | 187 | 121 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.23e-05 | 187 | 121 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 188 | 121 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.31e-05 | 189 | 121 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 189 | 121 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.35e-05 | 190 | 121 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 190 | 121 | 6 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.39e-05 | 191 | 121 | 6 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.39e-05 | 191 | 121 | 6 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.39e-05 | 191 | 121 | 6 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.43e-05 | 192 | 121 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.43e-05 | 192 | 121 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 193 | 121 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 1.47e-05 | 193 | 121 | 6 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-05 | 194 | 121 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-05 | 194 | 121 | 6 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 194 | 121 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-05 | 194 | 121 | 6 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.51e-05 | 194 | 121 | 6 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 196 | 121 | 6 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 196 | 121 | 6 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.61e-05 | 196 | 121 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 197 | 121 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.65e-05 | 197 | 121 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-05 | 197 | 121 | 6 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 197 | 121 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.65e-05 | 197 | 121 | 6 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-05 | 197 | 121 | 6 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 197 | 121 | 6 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 198 | 121 | 6 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 198 | 121 | 6 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 198 | 121 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-05 | 198 | 121 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 198 | 121 | 6 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-05 | 198 | 121 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 199 | 121 | 6 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; HL60; HG-U133A | 1.13e-06 | 199 | 120 | 9 | 2003_UP | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.68e-06 | 190 | 120 | 8 | 7145_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 4987_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 6785_UP | |
| Disease | Intellectual Disability | 1.52e-05 | 447 | 120 | 10 | C3714756 | |
| Disease | metalloproteinase inhibitor 4 measurement | 1.64e-05 | 2 | 120 | 2 | EFO_0801797 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.31e-05 | 14 | 120 | 3 | DOID:9743 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | COL2A1 ARHGAP42 USP36 HIP1 TRPM7 NEK7 POGZ PI15 PDLIM5 CDKAL1 RNF215 LATS2 SUGCT TRIM8 FER1L5 HYDIN CDH13 | 4.91e-05 | 1392 | 120 | 17 | EFO_0005763 |
| Disease | risk-taking behaviour | MYT1L ACTR10 NEK7 CDH23 REV3L TENM2 CASP12 CDH22 CADPS TRIM8 PCDH7 CDH13 | 6.84e-05 | 764 | 120 | 12 | EFO_0008579 |
| Disease | diabetes mellitus (is_implicated_in) | 2.22e-04 | 29 | 120 | 3 | DOID:9351 (is_implicated_in) | |
| Disease | biological sex | 3.66e-04 | 230 | 120 | 6 | PATO_0000047 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.02e-04 | 152 | 120 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | plasma renin activity measurement | 5.80e-04 | 9 | 120 | 2 | EFO_0006828 | |
| Disease | rectum cancer (is_implicated_in) | 5.80e-04 | 9 | 120 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder | 6.29e-04 | 354 | 120 | 7 | EFO_0003888 | |
| Disease | anthropometric measurement | 6.34e-04 | 168 | 120 | 5 | EFO_0004302 | |
| Disease | respiratory syncytial virus infectious disease (is_implicated_in) | 7.23e-04 | 10 | 120 | 2 | DOID:1273 (is_implicated_in) | |
| Disease | cholesteryl ester 20:5 measurement | 7.69e-04 | 44 | 120 | 3 | EFO_0010349 | |
| Disease | diabetic retinopathy (is_implicated_in) | 1.12e-03 | 50 | 120 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | sitting height ratio | 1.18e-03 | 51 | 120 | 3 | EFO_0007118 | |
| Disease | Drug habituation | 1.27e-03 | 115 | 120 | 4 | C0013170 | |
| Disease | Drug abuse | 1.27e-03 | 115 | 120 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.27e-03 | 115 | 120 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.27e-03 | 115 | 120 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.27e-03 | 115 | 120 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.27e-03 | 115 | 120 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.27e-03 | 115 | 120 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.27e-03 | 115 | 120 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.27e-03 | 115 | 120 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.31e-03 | 116 | 120 | 4 | C0740858 | |
| Disease | neutrophil count | SPATA6L NEK7 NSD1 KRI1 CDH23 POGZ ZMIZ1 CIT CDKAL1 SNX13 GTF3C1 SYN2 SSH2 HYDIN | 1.49e-03 | 1382 | 120 | 14 | EFO_0004833 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.63e-03 | 801 | 120 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 1.66e-03 | 15 | 120 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | acne | 1.73e-03 | 125 | 120 | 4 | EFO_0003894 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 1.90e-03 | 16 | 120 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | metabolite measurement | 2.10e-03 | 560 | 120 | 8 | EFO_0004725 | |
| Disease | carcinoma (implicated_via_orthology) | 2.28e-03 | 64 | 120 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.49e-03 | 66 | 120 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | bipolar disorder | 2.53e-03 | 577 | 120 | 8 | MONDO_0004985 | |
| Disease | Microcephaly | 2.60e-03 | 67 | 120 | 3 | C0025958 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 2.68e-03 | 19 | 120 | 2 | EFO_0002609, GO_0031427 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.68e-03 | 19 | 120 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | diabetes mellitus | 2.71e-03 | 68 | 120 | 3 | EFO_0000400 | |
| Disease | fasting blood insulin measurement | 2.83e-03 | 69 | 120 | 3 | EFO_0004466 | |
| Disease | nose morphology measurement, mouth morphology measurement | 3.27e-03 | 21 | 120 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Schizophrenia | 3.29e-03 | 883 | 120 | 10 | C0036341 | |
| Disease | colorectal cancer | 3.34e-03 | 604 | 120 | 8 | MONDO_0005575 | |
| Disease | lung cancer (is_implicated_in) | 3.45e-03 | 74 | 120 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | 3.54e-03 | 610 | 120 | 8 | EFO_0007990 | |
| Disease | myeloperoxidase (MPO)-DNA complex measurement | 3.59e-03 | 22 | 120 | 2 | EFO_0011039 | |
| Disease | diet measurement | MYT1L KIF26B GRIK5 ME1 KHDC4 CIT TENM2 CDH22 CADPS PCDH7 CDH13 | 3.72e-03 | 1049 | 120 | 11 | EFO_0008111 |
| Disease | RS-6-hydroxywarfarin measurement | 3.75e-03 | 155 | 120 | 4 | EFO_0803328 | |
| Disease | unipolar depression, bipolar disorder | 3.84e-03 | 156 | 120 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | diffuse plaque measurement | 3.87e-03 | 758 | 120 | 9 | EFO_0010699 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.92e-03 | 23 | 120 | 2 | C1335177 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 3.92e-03 | 23 | 120 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 3.92e-03 | 23 | 120 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.93e-03 | 157 | 120 | 4 | DOID:14330 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGPINNMKNVFAEPQ | 356 | Q9HAC7 | |
| QGAMYAFPRIFIPAK | 436 | Q8TD30 | |
| VTMNLNGAYPKLVPF | 946 | Q4VNC1 | |
| GQQKPTAYVRPMDGQ | 281 | P51816 | |
| IHTIFPPNGMNLYKN | 611 | Q9NZU0 | |
| RMNPISGKPEPYQAF | 481 | Q32M45 | |
| IRQQTPDKPSPNMFY | 286 | P55290 | |
| ANMPGLNIRNKEFNY | 96 | Q6UXS9 | |
| DMPNTNKYSFDGANP | 3116 | Q9H251 | |
| RLNLFFQGKPPFMTQ | 26 | O14578 | |
| YGNQLDEFPMNLPKN | 96 | O43155 | |
| AGMPKPVRVVQYNIN | 46 | Q9NZ32 | |
| KGPDPLQYMRADQAA | 1231 | P02458 | |
| QKYPPTVMQNKGFRC | 1621 | Q96L73 | |
| SMLPEPGYNINNRIA | 371 | Q8IXN7 | |
| YPFNAKQPTDMARRQ | 131 | Q9ULU8 | |
| AAPLNPGMYSQKAAR | 91 | Q00444 | |
| PKGRPNTMNNYGVLL | 166 | Q6N063 | |
| PEPQNKEAFVRSQMY | 531 | P48163 | |
| LPAQFKQRAPMYNSG | 366 | Q9H3P2 | |
| SQPNYRPQGMEGFLK | 36 | Q96T17 | |
| GYFPRDNLRMKNDPL | 636 | Q14703 | |
| QQQMRATPKFGPYQK | 61 | Q9NRM7 | |
| VLTNYMFPQQPRGDE | 421 | Q96NW7 | |
| TNAMFKNNYPSLTPQ | 126 | P51654 | |
| PKMNFANVFIGANPL | 266 | Q16539 | |
| FQQQMIYDSPPSRAP | 236 | Q13480 | |
| QKRGNQVPPKMFAFD | 496 | Q2KJY2 | |
| AEMFAKGQPVAPYNT | 191 | O94992 | |
| GKAEYPPGMRQQVFQ | 96 | Q86V87 | |
| FYVKENLQPNSPVGM | 646 | O60245 | |
| SEIKFNSYNNAGMPP | 591 | Q9H792 | |
| FQPQKALRPDMGYNT | 16 | Q8TDX7 | |
| PRTQQPKLFEGNMHY | 541 | O60462 | |
| GQMLYTQPPLKFVRA | 336 | Q96RN5 | |
| NSVRLQPPKQGMQYY | 206 | Q969V5 | |
| NFNMDADYDPSQPRK | 451 | Q8N9T8 | |
| PKARLAFQNMNGSEY | 486 | Q13421 | |
| NNMAYNKAPRPFGSV | 121 | Q96HC4 | |
| FKDFMQPPASRVQNG | 1701 | Q7Z3U7 | |
| KLLPGYYMNLNQNPR | 206 | Q99755 | |
| KVYGAVMNINRGNPF | 26 | Q5SZD4 | |
| YMNAAGVPKQSLNGP | 1986 | Q92794 | |
| PQPDKPMFFYVTQGQ | 751 | Q92900 | |
| DGYQMAQPAFAPKNI | 871 | P07333 | |
| AQPAFAPKNIYSIMQ | 876 | P07333 | |
| YNKGSIDALFNMTPP | 486 | Q4G0P3 | |
| PNIRNSLENVYMYKP | 81 | A2AJT9 | |
| AFQPLVKNYQPCNGM | 336 | O00115 | |
| VKNYQPCNGMARKPS | 341 | O00115 | |
| LFDVPSLNGVYPRMN | 476 | Q8NHQ1 | |
| NERFNVYLMPTPNLD | 136 | Q6PKX4 | |
| INQFYPRPGTPAAKM | 391 | Q5VV42 | |
| PKNRNPAFMNRAYPK | 866 | Q6ZTQ4 | |
| NYVGMQNCPKDGFPV | 511 | Q8N4A0 | |
| YQSAKPALDSNLFPM | 176 | Q06889 | |
| VPEQFRDMPYQPFSK | 21 | O15371 | |
| QCLRMGKERYNFPNP | 326 | O15371 | |
| AKNMNVRPLLNYFEP | 576 | Q9BYF1 | |
| AFEPPKYLMLGQQAV | 271 | Q5SZL2 | |
| RQGPQSKQPFMVAFF | 291 | P22003 | |
| KRYSGAFPPQLRAQM | 116 | Q92611 | |
| LQKMDRPNGLYPNYL | 366 | O60476 | |
| QYPSSQPRAKQQMPF | 596 | Q7Z7F0 | |
| NPNEPAKMNFSYGLT | 496 | Q16678 | |
| NDNPPRFPQKMYQFS | 271 | Q9UJ99 | |
| PYVMRRPNFQALSGN | 426 | Q16478 | |
| FRNYQRKNDMDEPPS | 571 | Q14839 | |
| PRYAILNEPFKGEMN | 1756 | Q14839 | |
| AKSFLGYNPMIPAEN | 2971 | Q8IVF4 | |
| SLPEPERNYNLQMSG | 911 | P21817 | |
| MAPERINPELNQKGY | 231 | P46734 | |
| PVFNPVTYSLRNNDM | 281 | Q96R54 | |
| MQPDSPLRNNYQGFL | 156 | Q6ICC9 | |
| PTQQAAKAMQRFEPG | 2621 | Q5T011 | |
| ANLPNGYMTDLQRPE | 16 | Q92777 | |
| NLPNGYMTDLQRPDS | 16 | O14994 | |
| NTPIPYRNQGNLMKL | 486 | A2RUB1 | |
| LPPGDFQNKIMRYFV | 236 | Q9Y5W8 | |
| RYNPSESPFAMAQIQ | 621 | Q8NBS3 | |
| NRLPKGMQARAPSQY | 176 | Q8N4H0 | |
| LNGKRIPYFPANQEM | 381 | Q8N142 | |
| FRKNNPGKPYARMCI | 461 | Q7Z6J9 | |
| PKAMNNFYDNIEPGP | 606 | Q8N5C8 | |
| PDGLMYQKFRNQFLS | 211 | Q9BXJ8 | |
| MNPRGLFQDFNPSKF | 1 | Q9H7F4 | |
| ADYFAVPVQNKMNPA | 296 | Q8NDG6 | |
| GNRDMYQPNTLDPIF | 1521 | A0AVI2 | |
| QRMKSANQDYRPPSQ | 251 | A6NI28 | |
| PTLVFYRGQMDQPAN | 1171 | Q7Z3K3 | |
| EYHTKNPRFPGNLQM | 151 | O00291 | |
| QIGRNFYNPSEPMEI | 221 | Q7Z3Z4 | |
| KEPTGFSLNNPMYVR | 316 | Q7Z5V6 | |
| SGPQAYPKALVQQMR | 131 | Q9Y6U7 | |
| PYVNVGALRMPFQQD | 221 | O60902 | |
| MENRPGSFQYVPVQL | 1 | Q9ULL8 | |
| RMPNIGFQNLPLNIY | 11 | Q9Y225 | |
| KNVGKEPAPFNLYMF | 2446 | Q9NT68 | |
| AAFKMENSSYLPNPL | 6 | Q5VTB9 | |
| NFRNKRGQMPENPYS | 976 | Q9UPX8 | |
| FYNPVVPEAQKREMG | 146 | O15551 | |
| ESSGQQNPKPYMRKF | 2351 | A4UGR9 | |
| PQVQRPSFMDYFDKQ | 386 | Q13188 | |
| PYGLKNLRPEFMQMQ | 386 | O75762 | |
| NRMPSPCRSFGNNKY | 431 | O60673 | |
| PNPSFMRQLEEYQGI | 431 | Q76I76 | |
| AMRENPYANAGKNPD | 291 | O95391 | |
| GKDPAPFNLYMFRNN | 2376 | Q9P273 | |
| LVPNGAIPQGKFYEM | 566 | Q8IZJ1 | |
| PKFQEQFLNVSGMPQ | 306 | Q86X10 | |
| NRKMVPVPEGAYGNF | 21 | O15195 | |
| ALSPNAKEFIFPNMQ | 266 | P50616 | |
| TKARFLYGENMPPQD | 236 | P33981 | |
| QVRGKVFPPAANMEY | 76 | O43692 | |
| NRALPFVPMSYQLSQ | 1491 | Q12789 | |
| AAQQPMLPQYGGRKI | 451 | Q9BZR9 | |
| SLNPMNFIQPGAFKE | 211 | O00206 | |
| NYSGNLMEPPFQNQK | 186 | O14530 | |
| YEVNLKDFEPQPGNM | 1056 | Q93009 | |
| ELYNTKQGPTNPMLF | 476 | Q96QT4 | |
| PEFLNIRPYMSQNNG | 346 | Q9P275 | |
| NKDINQYGPMGPTQA | 311 | Q9ULJ6 | |
| FNQPVKLYSMKFQGP | 171 | O43396 | |
| MPCRNQGYILDGFPK | 471 | Q96M32 | |
| KFIGMIVSPYNRNNP | 686 | Q5VVJ2 | |
| NMRSYEDQSPRQLPG | 461 | Q9UL68 |